Post-translational modifications: The potential ways for killing cancer stem cells.

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Cancer metastasis and recurrence remain significant challenges in cancer treatment, contributing to high mortality rates.
• Cancer stem cells (CSCs) are implicated in tumor recurrence and metastasis due to their therapy resistance and invasive potential.
• CSCs possess self-renewal, differentiation, and tumorigenesis capabilities, making their eradication a critical therapeutic goal.

Purpose of the Study:

• To review the role of post-translational protein modifications (PTMs) in regulating CSC self-renewal and replication.
• To highlight the significance of PTMs and their crosstalk in controlling CSC behavior.
• To explore PTM manipulation as a novel therapeutic strategy against CSCs.

Main Methods:

• Literature review focusing on recent investigations into PTMs and CSCs.
• Analysis of the interplay between various PTMs and their impact on CSC functions.
• Synthesis of current knowledge on PTM regulation in cancer stem cell biology.

Main Results:

• Post-translational protein modifications (PTMs) play a crucial role in governing CSC self-renewal and replication.
• PTM crosstalk significantly influences CSC behavior and contributes to their survival and proliferation.
• Specific PTMs are identified as key regulators of CSC capabilities.

Conclusions:

• Targeting PTMs represents a novel and promising therapeutic avenue for eliminating CSC populations.
• Manipulation of PTMs offers a potential strategy to overcome therapeutic resistance in cancer.
• Further research into PTMs could lead to innovative cancer treatment approaches.